- Home
- IPW vs BLRX Comparison
IPW vs BLRX Comparison
Compare IPW & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- BLRX
- Stock Information
- Founded
- IPW 2018
- BLRX 2003
- Country
- IPW United States
- BLRX Israel
- Employees
- IPW N/A
- BLRX N/A
- Industry
- IPW Catalog/Specialty Distribution
- BLRX Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- BLRX Health Care
- Exchange
- IPW Nasdaq
- BLRX Nasdaq
- Market Cap
- IPW 18.3M
- BLRX 17.1M
- IPO Year
- IPW 2021
- BLRX 2011
- Fundamental
- Price
- IPW $18.00
- BLRX $3.62
- Analyst Decision
- IPW
- BLRX Strong Buy
- Analyst Count
- IPW 0
- BLRX 2
- Target Price
- IPW N/A
- BLRX $19.00
- AVG Volume (30 Days)
- IPW 24.8K
- BLRX 29.2K
- Earning Date
- IPW 10-09-2025
- BLRX 11-24-2025
- Dividend Yield
- IPW N/A
- BLRX N/A
- EPS Growth
- IPW N/A
- BLRX N/A
- EPS
- IPW N/A
- BLRX N/A
- Revenue
- IPW $66,142,779.00
- BLRX $17,251,000.00
- Revenue This Year
- IPW $149.67
- BLRX N/A
- Revenue Next Year
- IPW $15.04
- BLRX N/A
- P/E Ratio
- IPW N/A
- BLRX N/A
- Revenue Growth
- IPW N/A
- BLRX 1.19
- 52 Week Low
- IPW $12.38
- BLRX $2.30
- 52 Week High
- IPW $46.20
- BLRX $22.60
- Technical
- Relative Strength Index (RSI)
- IPW 69.82
- BLRX 43.04
- Support Level
- IPW $0.47
- BLRX $3.50
- Resistance Level
- IPW $29.10
- BLRX $3.89
- Average True Range (ATR)
- IPW 1.26
- BLRX 0.23
- MACD
- IPW 2.56
- BLRX -0.04
- Stochastic Oscillator
- IPW 63.66
- BLRX 18.60
About IPW iPower Inc.
iPower Inc is a United States-based online retailer and supplier of consumer home, pet, garden, outdoor, and consumer electronics products. It also operates as a provider of value-added ecommerce services for third-party products and brands. The company's capabilities include a spectrum of online channels, fulfillment capacity, a network of warehouses serving the U.S., last-mile delivery partners, and a differentiated business intelligence platform. The company's sales channels currently include Amazon Vendor, Amazon 3P, Walmart.com, TikTok, Temu, and other marketplaces, as well as its own e-commerce websites, such as simpledeluxe.com and more. Additionally, it is developing in-house branded products and through supply chain partners, which include iPower, Simple Deluxe, and other brands.
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.